FAQ — Nordic Cell Therapy Group

Frequently asked questions about our activities, collaboration models, analytical capabilities, and approach to cell therapy development.
WHAT TYPES OF PROJECTS DO YOU SUPPORT?
We focus exclusively on cell therapy. Across our divisions, we support biotech companies, start-ups, and academic groups in areas including scientific strategy, assay development, CMC, translational planning, and therapeutic program development.

WHAT IS YOUR MAIN GOAL?
Our goal is to accelerate the development of next-generation cell therapies by combining scientific expertise, analytical capabilities, and translational development experience.

ARE YOUR CONSULTING AND THERAPEUTIC PROGRAMS SEPARATE?
Yes. Our consulting activities and internal therapeutic programs operate independently to avoid conflicts of interest and ensure confidentiality across all collaborations.

HOW DO YOU TYPICALLY START WORKING WITH A NEW PARTNER?
We begin with an initial discussion to understand the scientific, technical, and strategic needs of each project. Based on this, we define a focused scope of work with clear priorities, timelines, and deliverables.

DO YOU OFFER CUSTOMIZED ANALYTICAL OR ASSAY DEVELOPMENT?
Yes. In addition to our existing analytical offerings, we work with partners to develop tailored analytical strategies and assays adapted to specific cell types, manufacturing processes, and development challenges.

HOW IS YOUR PRICING STRUCTURED?
We offer flexible collaboration models including hourly consulting, defined project scopes, and longer-term strategic support agreements depending on the needs of each engagement.

DO YOU SIGN NDAS?
Yes. Confidentiality and protection of intellectual property are fundamental to how we operate, and we routinely work under mutual non-disclosure agreements.

DO YOU WORK ONLY WITH ESTABLISHED COMPANIES?
No. We support organizations at different stages, ranging from academic projects and early start-ups to established biotech and industry partners.

DO YOU ENGAGE WITH INVESTORS OR STRATEGIC PARTNERS?
Yes. In parallel with supporting external collaborations, we actively engage with investors and strategic partners interested in the advancement of innovative cell therapy programs.
Contact us

Copenhagen, 2300, Denmark
Nordic Cell Therapy Group Aps, a Danish private limited company
(CVR-nummer 46007441)